Skip to main content

Table 1

From: An audit to assess the impact of introducing a protocol of bilateral whole breast and axillary ultrasound for assessment of screen-detected cancers

 

Audit (n = 1,700)

Control (n = 105)

Additional biopsy

318 (19%)

6 (5.7%)

Additional biopsy shows cancer

160 (9.4%)

6 (5.7%)

Contralateral biopsies

47 (2.8%)

0 (0%)

Bilateral cancer

22 (1.3%)

0 (0%)

FNAC of axillary node

150 (8.8%)

0 (0%)

FNAC shows nodal metastases

55 (3.2%)

0 (0%)